Schuman warns home tonometry faces hurdles

Glaucoma care is about measuring change before vision loss becomes obvious. That is why home tonometry sounds so appealing — instead of catching eye pressure during one clinic visit, patients could measure it over days, including the spikes that happen at night or early morning. Joel S. Schuman, a glaucoma specialist at Wills Eye, argues that this whole remote-monitoring stack is getting close: home pressure checks, virtual visual fields, and portable OCT imaging. But his real point is not that the tech is weak. It is that the hard part now is getting it to fit real care. (ophthalmologytimes.com) ### What is home tonometry, exactly? Home tonometry means patients measure intraocular pressure themselves, usually with a handheld rebound tonometer such as iCare HOME. That matters because pressure is still the main modifiable glaucoma risk factor, and office readings miss a lot of the day. The(ophthalmologytimes.com)se is simple — more measurements, taken in real life, should give a truer picture than one office snapshot. (eyewiki.org) ### Why are doctors excited now? Because the rest of the home-testing package is maturing too. Schuman points to virtual reality visual field testing and early portable or kiosk OCT systems alongside home tonometry. A recent Stanford-led pilot showed that unsupervised home testing with VR visual fields plus iCare HOME was feasible and had potential to supplement clinic testing. In other words, th(eyewiki.org)— it is starting to look like a remote glaucoma workflow. (ophthalmologytimes.com) ### So what is the snag? Data quality. A home device can be technically good and still produce messy clinical information if patients use it inconsistently, use it incorrectly, or only test when they feel motivated. Schuman flags reliability and adherence as major barriers. That is the core tension here: more data is only better if the data is trustworthy. Otherwise a doctor gets a bigger spreadsheet, not a clearer patient story. (ophthalmologytimes.com) ### Why does clinician workload matter so much? Because remote monitoring creates a triage problem. If dozens or hundreds of patients start sending pressure readings, visual field outputs, and imaging files from home, someone has to review them, decide what is actionable, and document the respons(ophthalmologytimes.com)surface the signal without drowning doctors in noise. (ophthalmologytimes.com) ### Isn’t reimbursement the usual bottleneck? Basically, yes. Schuman explicitly points to unclear reimbursement as a brake on rollout. That matters because glaucoma care already involves repeated testing, coding rules, and audit risk. A clinic may hesitate to build a remote-monitoring program if(ophthalmologytimes.com)policy is often the bridge between them. (ophthalmologytimes.com) ### Does that mean the technology is overhyped? Not really. The literature Schuman is pointing at is more encouraging than dismissive. Home tonometry has shown useful correlation with Goldmann applanation tonometry, though some reports note it can read lower by around 2 mmHg across a broad range. (ophthalmologytimes.com)is not whether home measurement can work. It is whether the system around it can work consistently. (reviewofophthalmology.com) ### Why does this matter beyond glaucoma? Because this is where a lot of medical technology stalls. The invention problem gets solved first. Then turns out the real fight is behavior, workflow, liability, and payment. Schuman’s point lands because it is broader than ophthalmology — healthcare does not adopt tools just because they are clever. It adopts tools when they are reliable enough, easy enough, and paid for clearly enough. (ophthalmologytimes.com) ### Bottom line The near-term glaucoma story is no longer “can we build home monitoring?” It is “can clinics absorb it?” Schuman’s answer is cautiously optimistic — but only if the field treats operations as seriously as invention. (ophthalmologytimes.com)